Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

26.38
-0.0350-0.13%
Volume:305.18K
Turnover:8.00M
Market Cap:10.30B
PE:-3.28
High:26.41
Open:26.07
Low:26.07
Close:26.41
52wk High:48.92
52wk Low:23.04
Shares:390.68M
Float Shares:363.29M
Volume Ratio:5.03
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0516
EPS(LYR):-9.2734
ROE:-29.32%
ROA:-15.49%
PB:1.10
PE(LYR):-2.84

Loading ...

Wolfe Adjusts Price Target on Moderna to $16 From $20, Maintains Underperform Rating

MT Newswires Live
·
Oct 23

Moderna Is Maintained at Neutral by Citigroup

Dow Jones
·
Oct 23

Moderna price target lowered to $28 from $30 at Citi

TIPRANKS
·
Oct 23

BUZZ-Moderna shares fall after birth defect vaccine trial misses target

Reuters
·
Oct 23

Moderna Shares Down 4.3% Premarket After Co Halts Development of Birth Defect Vaccine Following Trial Setback

THOMSON REUTERS
·
Oct 23

U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic

Reuters
·
Oct 23

Moderna : Leerink Partners Cuts Target Price to $12 From $16

THOMSON REUTERS
·
Oct 23

24H | Crypto Shares Jump With Bitfarms up Nearly 6%; Rare Earth Stocks Gain with American Resources up over 3%; Moderna Falls Nearly 4%

Tiger Newspress
·
Oct 23

Stock Track | Moderna Plunges 5.40% After-Hours as CMV Vaccine Fails in Phase 3 Trial

Stock Track
·
Oct 23

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (Cmv) Vaccine Did Not Meet Primary Efficacy Endpoint

THOMSON REUTERS
·
Oct 23

Moderna - Does Not Anticipate Any Impact to Its 2025 Financial Guidance or Its Expectation of Achieving Breakeven in 2028

THOMSON REUTERS
·
Oct 23

Moderna: Will Continue to Evaluate Mrna-1647 in Ongoing Phase 2 Trial in Bone Marrow Transplant Patients

THOMSON REUTERS
·
Oct 23

Moderna - to Discontinue Development of Mrna-1647 in Congenital Cmv

THOMSON REUTERS
·
Oct 23

Moderna Halts CMV Vaccine Development After Phase 3 Trial Misses Efficacy Endpoint

Reuters
·
Oct 23

Health Rounds: mRNA COVID vaccines appear to make immunotherapy cancer drugs work better

Reuters
·
Oct 22

Moderna (MRNA) Gets a Hold from Bernstein

TIPRANKS
·
Oct 21

Moderna Publishes Study on mRNA-1345 RSV Vaccine in Solid Organ Transplant Recipients

Reuters
·
Oct 21

Moderna Inc. Stock Rises 4.7%, Outperforms Peers

Dow Jones
·
Oct 21

Small Caps Rally As Credit Fears Ease, Gold Rebounds To $4,350: What's Moving Markets Monday?

Benzinga_recent_news
·
Oct 21

Super Micro Is 1 of the S&P 500's Top Gainers. The Stock Could Break Out. -- Barrons.com

Dow Jones
·
Oct 21